Wyrick Susan D. 4
4 · Sana Biotechnology, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Wyrick Susan D.
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2026-03-02+1,525→ 187,408 total - Tax Payment
Common Stock
2026-03-03$3.91/sh−491$1,920→ 186,917 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-03-02−1,525→ 1,525 total→ Common Stock (1,525 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
- [F2]The award vested as to 25% of the restricted stock units on each of March 2, 2024, 2025 and 2026, and the remaining restricted stock units will vest on March 2, 2027, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date.
Signature
/s/ Aaron M. Grossman, Attorney-in-Fact for Susan D. Wyrick|2026-03-04